Inventor · disambiguated record
Philippe Moullier
Also filed as: MOULLIER PHILIPPE
8 granted patents·8 pending applications·278 citations·filing 1994–2024
88Inventor score
Files withASKLEPIOS BIOPHARMACEUTICAL INC4GENETHON3PASTEUR INSTITUT3COAVE THERAPEUTICS2AVENTIS PHARMA SA1
Top patents by PatentIndex Score
16 records- 0193US11382988B2Modified adeno-associated virus vectors and delivery thereof into the central nervous systemCOAVE THERAPEUTICS·Filed 2021·Granted Jul 12, 2022·4 cites·26 claims
- 0293US10166272B2Efficient systemic treatment of dystrophic muscle pathologiesGENETHON·Filed 2015·Granted Jan 1, 2019·16 cites·12 claims
- 0392US5906817ABiocompatible implant for the expression and in vivo secretion of a therapeutic substancePASTEUR INSTITUT·Filed 1994·Granted May 25, 1999·171 cites·35 claims
- 0488US10786546B2Efficient systemic treatment of dystrophic muscle pathologiesGENETHON·Filed 2018·Granted Sep 29, 2020·3 cites·6 claims
- 0574US6509150B1Compositions and methods for recombinant Adeno-Associated Virus productionUNIV NANTES·Filed 1999·Granted Jan 21, 2003·46 cites·24 claims
- 0672US6464998B1Composition for the in vivo production of therapeutic productsAVENTIS PHARMA SA·Filed 1994·Granted Oct 15, 2002·28 cites·25 claims
- 0771US2025121097A1Methods of recombinant adeno-associated virus kidney administrationASKLEPIOS BIOPHARMACEUTICAL INC·Filed 2024·Application pending·0 cites
- 0870US12023366B2Efficient systemic treatment of dystrophic muscle pathologiesGENETHON·Filed 2020·Granted Jul 2, 2024·0 cites·9 claims
- 0963US2022323610A1Modified adeno-associated virus vectors and delivery thereof into the central nervous systemCOAVE THERAPEUTICS·Filed 2022·Application pending·0 cites
- 1056US2025109398A1Compositions for treating neurological diseaseASKLEPIOS BIOPHARMACEUTICAL INC·Filed 2023·Application pending·0 cites
- 1156US2023340470A1Methods for treating huntington's diseaseASKLEPIOS BIOPHARMACEUTICAL INC·Filed 2020·Application pending·0 cites
- 1254US2023365963A1Methods for treating neurological diseaseASKLEPIOS BIOPHARMACEUTICAL INC·Filed 2021·Application pending·0 cites
- 1353US6326195B1Recombinant retroviral vectorPASTEUR INSTITUT·Filed 1999·Granted Dec 4, 2001·10 cites·16 claims
- 1446US2002098223A1Biocompatible implant for the expression and in vivo secretion of a therapeutic substancePASTEUR INSTITUT·Filed 2001·Application pending·0 cites
- 1541US2002064878A1Compositions and methods for recombinant adeno-associated virus productionFiled 2001·Application pending·0 cites
- 1637US2004014031A1Inducible highly productive rAAV packaging cell-linesFiled 2002·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Philippe Moullier files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →